The transformation and innovation development of biopharmaceutical industry under the background of aging

DOI

10.2991/icfied-17.2017.8How to use a DOI?

Keywords

Aging, biopharmaceutical industry, strategic emerging industries, innovation development, transformation

Abstract

With the acceleration of population aging process, the elderly industry has been paid more attention. It will effectively promote transformation and innovation development of the third industry, especially the biopharmaceutical industry. From now to 2030, the aging will develop rapidly. The change of population aging would be adapted only by speeding up the transformation of economic structure and the construction of the pharmaceutical industry. Consequently, biopharmaceutical industry, which is one of the strategic emerging industries should find a new way to adapt to its new opportunities and challenges. In this study, the strategic position, emphasis and difficulty of transformation and innovation development of biopharmaceutical industry under the background of the rapid aging was summarized and a feasible strategy measure was proposed.

Copyright

© 2017, the Authors. Published by Atlantis Press.

Open Access

This is an open access article distributed under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).

Download article (PDF)

TY  - CONF
AU  - Jiao Feng
AU  - Yan Zhu
AU  - Jie Zhang
PY  - 2017/04
DA  - 2017/04
TI  - The transformation and innovation development of biopharmaceutical industry under the background of aging
BT  - Proceedings of the 2017 2nd International Conference on Financial Innovation and Economic Development (ICFIED 2017)
PB  - Atlantis Press
SP  - 42
EP  - 45
SN  - 2352-5428
UR  - https://doi.org/10.2991/icfied-17.2017.8
DO  - 10.2991/icfied-17.2017.8
ID  - Feng2017/04
ER  -